Dashenlin Pharm Grp Co Ltd Financial Flexibility Index
Dashenlin Pharm Grp Co Ltd financial flexibility index. Dashenlin Pharm Grp Co Ltd (603233) has a Financial Flexibility Index of 0.06x as of September 2025. Free cash flow of CN¥980.14 Million (operating CF CN¥818.72 Million minus capex CN¥161.42 Million) represents 0% of total liabilities (CN¥17.59 Billion). See 603233 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Dashenlin Pharm Grp Co Ltd (2012–2025)
Financial flexibility index of Dashenlin Pharm Grp Co Ltd from 2012 to 2025. Historical Financial Flexibility Index trend for Dashenlin Pharm Grp Co Ltd across 14 annual periods. Check Dashenlin Pharm Grp Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Dashenlin Pharm Grp Co Ltd Financial Flexibility Index by Year (2012–2025)
Dashenlin Pharm Grp Co Ltd financial flexibility index by year from 2012 to 2025. Year-by-year free cash flow to debt coverage for Dashenlin Pharm Grp Co Ltd. For the full cash flow conversion analysis, see 603233 cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.33x | CN¥5.84 Billion | CN¥5.35 Billion | CN¥17.83 Billion | ▲ +30.7% |
| 2024 | 0.25x | CN¥4.58 Billion | CN¥3.11 Billion | CN¥18.30 Billion | ▼ -18.4% |
| 2023 | 0.31x | CN¥4.97 Billion | CN¥3.17 Billion | CN¥16.19 Billion | ▼ -10.4% |
| 2022 | 0.34x | CN¥4.79 Billion | CN¥3.76 Billion | CN¥13.98 Billion | ▲ +37.1% |
| 2021 | 0.25x | CN¥2.85 Billion | CN¥1.55 Billion | CN¥11.40 Billion | ▼ -38.5% |
| 2020 | 0.41x | CN¥2.75 Billion | CN¥1.95 Billion | CN¥6.76 Billion | ▼ -20.2% |
| 2019 | 0.51x | CN¥2.21 Billion | CN¥1.71 Billion | CN¥4.34 Billion | ▲ +23.0% |
| 2018 | 0.41x | CN¥1.43 Billion | CN¥873.64 Million | CN¥3.45 Billion | ▼ -4.5% |
| 2017 | 0.43x | CN¥1.31 Billion | CN¥640.39 Million | CN¥3.02 Billion | ▲ +20.8% |
| 2016 | 0.36x | CN¥802.96 Million | CN¥495.60 Million | CN¥2.24 Billion | ▼ -18.0% |
| 2015 | 0.44x | CN¥716.42 Million | CN¥468.59 Million | CN¥1.64 Billion | ▲ +10.3% |
| 2014 | 0.40x | CN¥710.39 Million | CN¥448.58 Million | CN¥1.79 Billion | ▼ -33.6% |
| 2013 | 0.60x | CN¥652.21 Million | CN¥288.22 Million | CN¥1.09 Billion | ▲ +5.4% |
| 2012 | 0.57x | CN¥349.16 Million | CN¥289.31 Million | CN¥615.39 Million | — |